Table 2.
CD34+ | CD44+ | CD45+ | CD146+ | CD29+ | Stro-1+ | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
p | OR | 95 % CI | p | OR | 95 % CI | p | OR | 95 % CI | p | OR | 95 % CI | p | OR | 95 % CI | p | OR | 95 % CI | |
Interval from injury to surgeryb, < 90 days | 0.025* | 6.043 | 1.259–28.995 | 0.011* | 8.440 | 1.615–44.111 | 0.015* | 16.144 | 1.701–153.212 | 0.015* | 9.246 | 1.541–55.461 | 0.369 | 1.982 | 0.446–8.819 | 0.059 | 4.559 | 0.944–22.020 |
10 ≤ age <20 year-oldc | 0.957 | 1.056 | 0.144–7.755 | 0.996 | 0.994 | 0.124–7.985 | 0.773 | 1.370 | 0.161–11.643 | 0.416 | 0.438 | 0.060–3.198 | 0.960 | 1.048 | 0.167–6.572 | 0.112 | 6.244 | 0.679–40.503 |
20 ≤ age <30 year-oldc | 0.027* | 2.020 | 1.413–26.512 | 0.795 | 1.370 | 0.127–14.775 | 0.593 | 1.954 | 0.189–20.215 | 0.178 | 0.176 | 0.016–1.888 | 0.593 | 0.569 | 0.071–4.575 | 0.577 | 1.919 | 0.194–18.972 |
Sexa Female | 0.683 | 0.692 | 0.118–4.057 | 0.593 | 0.604 | 0.097–3.780 | 0.092 | 7.535 | 0.717–79.179 | 0.139 | 4.148 | 0.629–27.374 | 0.218 | 0.368 | 0.075–1.809 | 0.843 | 1.194 | 0.207–6.897 |
Meniscal injuryd | 0.626 | 0.716 | 0.187–2.744 | 0.409 | 0.563 | 0.143–2.206 | 0.069 | 0.269 | 0.066–1.106 | 0.409 | 0.563 | 0.143–2.206 | 0.616 | 0.711 | 0.188–2.691 | 0.406 | 0.566 | 0.148–2.168 |
Chondral injuryd | 0.433 | 2.714 | 0.223–32.992 | 0.327 | 3.500 | 0.286–42.769 | 0.761 | 0.679 | 0.056–8.248 | 0.327 | 3.500 | 0.286–42.769 | 0.554 | 2.125 | 0.175–25.775 | 0.688 | 0.600 | 0.049–7.283 |
Combined meniscal or chondral injuriesd | 0.549 | 0.667 | 0.177–2.513 | 0.593 | 0.692 | 0.180–2.668 | 0.117 | 0.333 | 0.084–1.318 | 0.593 | 0.692 | 0.180–2.668 | 0.503 | 0.636 | 0.169–2.391 | 0.549 | 0.667 | 0.177–2.513 |
aUse “male” category as reference
bUse “interval more than 90 days” category as reference
cUse “age more than 30-year old” category as reference
dUse “no meniscal or chondral injuries” category as reference